Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2026-05-14 19:05:44 ET · period of report 2026-05-12 · accession 0001767584-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-14 19:05 | 2026-05-12 | ARWR | Lu Hongbo | Dir | S - Sale | $76.88 | -2,970 | 52.0K | -5% | -$228.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-12 | S | D | 2,970 | $76.88 | 52,012 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions. |